| SC 13G/A | 2024-02-14 | Flagship Ventures Fund V, L.P. | Sigilon Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-08-14 | ELI LILLY & Co | Sigilon Therapeutics, Inc. | 100 | 100.0% | EDGAR |
| SC 13D | 2023-07-07 | ELI LILLY & Co | Sigilon Therapeutics, Inc. | 1,008,830 | 40.3% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Sigilon Therapeutics, Inc. | 1,066,092 | 3.3% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Sigilon Therapeutics, Inc. | 1,736,557 | 5.4% | EDGAR |
| SC 13G | 2021-02-16 | Flagship Ventures Fund V, L.P. | Sigilon Therapeutics, Inc. | 8,888,888 | 28.5% | EDGAR |
| SC 13G | 2021-02-12 | ELI LILLY & Co | Sigilon Therapeutics, Inc. | 2,744,443 | 8.8% | EDGAR |